acuteandchronicadministrationofshr117887anovelandspecificdipeptidylpeptidase4inhibitorimprovesmetaboliccontrolindiabeticrodentmodels
文献类型：期刊论文
| 作者 | Liu Xiao1; Zhang Lina1; Ying Feng1; Zhang Lei2; Qu Hui1; Cao Guoqing2; Leng Ying1
|
| 刊名 | actapharmacologicasinica
 |
| 出版日期 | 2012 |
| 卷号 | 33期号:8页码:1013 |
| 关键词 | GLUCAGON-LIKE PEPTIDE-1 IMPROVED GLUCOSE-TOLERANCE DRUG-NAIVE PATIENTS BETA-CELL FUNCTION GLYCEMIC CONTROL IV INHIBITOR INSULIN-SECRETION DOUBLE-BLIND ZUCKER RATS EFFICACY SHR117887 vildagliptin (LAF237) dipeptidyl peptidase-4 (DPP-4) type 2 diabetes mellitus glucagon-like peptide-1 (GLP-1) insulin beta-cells |
| ISSN号 | 1671-4083 |
| DOI | 10.1038/aps.2012.75 |
| 英文摘要 | Aim: Dipeptidyl deptidase-4 (DPP-4) inhibitors are a new class of anti-diabetic agents. The purpose of this study was to assess the acute and chronic effects of SHR117887, a novel DPP-4 inhibitor, on metabolic control and pancreatic beta-cell function in normal or diabetic rodent models. |
| 语种 | 英语 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/284708]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | 1.中国科学院上海药物研究所 2.Shanghai Hengrui Pharmaceuticals Co, Ltd |
| 推荐引用方式 GB/T 7714 | Liu Xiao,Zhang Lina,Ying Feng,et al. acuteandchronicadministrationofshr117887anovelandspecificdipeptidylpeptidase4inhibitorimprovesmetaboliccontrolindiabeticrodentmodels[J]. actapharmacologicasinica,2012,33(8):1013. |
| APA | Liu Xiao.,Zhang Lina.,Ying Feng.,Zhang Lei.,Qu Hui.,...&Leng Ying.(2012).acuteandchronicadministrationofshr117887anovelandspecificdipeptidylpeptidase4inhibitorimprovesmetaboliccontrolindiabeticrodentmodels.actapharmacologicasinica,33(8),1013. |
| MLA | Liu Xiao,et al."acuteandchronicadministrationofshr117887anovelandspecificdipeptidylpeptidase4inhibitorimprovesmetaboliccontrolindiabeticrodentmodels".actapharmacologicasinica 33.8(2012):1013. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。